Dr. M. Walid Qoronfleh is the Director of Healthcare Research and Policy at Qatar Foundation-WISH. Dr. Qoronfleh leads the WISH Doha-based research unit which is engaged in research areas that are of immediate global and local healthcare relevance to Qatar.
The research is undertaken with a view to positively impacting healthcare research outcomes, health care innovation and health policies at the national level. These areas include autism, mental health, dementia, patient safety, non-communicable diseases, precision medicine and bioethics. Dr. Qoronfleh has over 20 years of scientific, technology, business, and commercial experience. He has held in the USA several senior management and executive positions with increasing responsibilities at a number of companies including GlaxoSmithKline, Sanofi, ThermoFisher, NextGen Sciences, SDIX and University of Michigan-Ann Arbor, with a particular focus on precision medicine.
Dr. Qoronfleh is the founder of three biotechnology companies and he is a co-founder and the Managing Director of the boutique consulting company Q3CG. Dr. Qoronfleh has published over 100 combined peer reviewed abstracts and papers. He is also an editor and an ad hoc reviewer for various scientific journals plus a frequent speaker at national and international conferences. He holds graduate degrees from The University of Louisville–School of Medicine, Penn State University and The University of Wisconsin–Madison.
